These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 29772470)

  • 1. Synthesis, molecular docking and xanthine oxidase inhibitory activity of 5-aryl-1H-tetrazoles.
    Fatima I; Zafar H; Khan KM; Saad SM; Javaid S; Perveen S; Choudhary MI
    Bioorg Chem; 2018 Sep; 79():201-211. PubMed ID: 29772470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and biological evaluation of 1-alkyl-5/6-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-1H-indole-3-carbonitriles as novel xanthine oxidase inhibitors.
    Gao J; Liu X; Zhang B; Mao Q; Zhang Z; Zou Q; Dai X; Wang S
    Eur J Med Chem; 2020 Mar; 190():112077. PubMed ID: 32014678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and bioevaluation of 3-oxo-6-aryl-2,3-dihydropyridazine-4-carbohydrazide derivatives as novel xanthine oxidase inhibitors.
    Zhang L; Wang S; Yang M; Shi A; Wang H; Guan Q; Bao K; Zhang W
    Bioorg Med Chem; 2019 May; 27(9):1818-1823. PubMed ID: 30885567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and biological evaluation of N-(3-cyano-1H-indol-5/6-yl)-6-oxo-1,6-dihydropyrimidine-4-carboxamides and 5-(6-oxo-1,6-dihydropyrimidin-2-yl)-1H-indole-3-carbonitriles as novel xanthine oxidase inhibitors.
    Zhang B; Duan Y; Yang Y; Mao Q; Lin F; Gao J; Dai X; Zhang P; Li Q; Li J; Dai R; Wang S
    Eur J Med Chem; 2022 Jan; 227():113928. PubMed ID: 34688012
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Gul A; Saad SM; Zafar H; Atia-Tul-Wahab ; Khan KM; Choudhary MI
    Med Chem; 2023; 19(4):384-392. PubMed ID: 35726432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and biological evaluation of 5-(1H-indol-5-yl)isoxazole-3-carboxylic acids as novel xanthine oxidase inhibitors.
    Huang D; Li W; Zhao Y; Xie C; Luo X; Wu F; Xu Z; Sun Q; Liu G
    Eur J Med Chem; 2024 May; 271():116443. PubMed ID: 38691887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xanthine oxidase inhibitory activity of nicotino/isonicotinohydrazides: A systematic approach from in vitro, in silico to in vivo studies.
    Zafar H; Hayat M; Saied S; Khan M; Salar U; Malik R; Choudhary MI; Khan KM
    Bioorg Med Chem; 2017 Apr; 25(8):2351-2371. PubMed ID: 28302506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xanthine Oxidase Inhibitory and Molecular Docking Studies on Pyrimidones.
    Zafar H; Iqbal S; Javaid S; Khan KM; Choudhary MI
    Med Chem; 2018; 14(5):524-535. PubMed ID: 29189174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, structure-activity relationships, and mechanistic studies of 5-arylazo-tropolone derivatives as novel xanthine oxidase (XO) inhibitors.
    Sato D; Kisen T; Kumagai M; Ohta K
    Bioorg Med Chem; 2018 Jan; 26(2):536-542. PubMed ID: 29274704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and Biological Evaluation of Novel Aryl-2H-pyrazole Derivatives as Potent Non-purine Xanthine Oxidase Inhibitors.
    Sun ZG; Zhou XJ; Zhu ML; Ding WZ; Li Z; Zhu HL
    Chem Pharm Bull (Tokyo); 2015; 63(8):603-7. PubMed ID: 26040271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xanthine oxidase inhibitors beyond allopurinol and febuxostat; an overview and selection of potential leads based on in silico calculated physico-chemical properties, predicted pharmacokinetics and toxicity.
    Šmelcerović A; Tomović K; Šmelcerović Ž; Petronijević Ž; Kocić G; Tomašič T; Jakopin Ž; Anderluh M
    Eur J Med Chem; 2017 Jul; 135():491-516. PubMed ID: 28478180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-Activity Relationships and Docking Studies of Hydroxychavicol and Its Analogs as Xanthine Oxidase Inhibitors.
    Nishiwaki K; Ohigashi K; Deguchi T; Murata K; Nakamura S; Matsuda H; Nakanishi I
    Chem Pharm Bull (Tokyo); 2018 Jul; 66(7):741-747. PubMed ID: 29695658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel 3-[4-alkoxy-3-(1H-tetrazol-1-yl) phenyl]-1,2,4-oxadiazol-5(4H)-ones as promising xanthine oxidase inhibitors: Design, synthesis and biological evaluation.
    Gao J; Zhang Z; Zhang B; Mao Q; Dai X; Zou Q; Lei Y; Feng Y; Wang S
    Bioorg Chem; 2020 Jan; 95():103564. PubMed ID: 31927335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of 4-(phenoxymethyl)-1H-1,2,3-triazole derivatives as novel xanthine oxidase inhibitors.
    Zhang TJ; Zhang Y; Zhang ZH; Wang ZR; Zhang X; Hu SS; Lu PF; Guo S; Meng FH
    Bioorg Med Chem Lett; 2022 Mar; 60():128582. PubMed ID: 35077850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of 1-hydroxy/methoxy-4-methyl-2-phenyl-1H-imidazole-5-carboxylic acid derivatives as non-purine xanthine oxidase inhibitors.
    Chen S; Zhang T; Wang J; Wang F; Niu H; Wu C; Wang S
    Eur J Med Chem; 2015 Oct; 103():343-53. PubMed ID: 26363870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, screening and docking of fused pyrano[3,2-d]pyrimidine derivatives as xanthine oxidase inhibitor.
    Kaur M; Kaur A; Mankotia S; Singh H; Singh A; Singh JV; Gupta MK; Sharma S; Nepali K; Bedi PMS
    Eur J Med Chem; 2017 May; 131():14-28. PubMed ID: 28286211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of hydroxychalcones as multifunctional non-purine xanthine oxidase inhibitors for the treatment of hyperuricemia.
    Xie Z; Luo X; Zou Z; Zhang X; Huang F; Li R; Liao S; Liu Y
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3602-3606. PubMed ID: 28655421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of 1-phenyl-1H-1,2,3-triazole-4-carboxylic acid derivatives as xanthine oxidase inhibitors.
    Zhang TJ; Wu QX; Li SY; Wang L; Sun Q; Zhang Y; Meng FH; Gao H
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3812-3816. PubMed ID: 28693909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational Analysis and Synthesis of Syringic Acid Derivatives as Xanthine Oxidase Inhibitors.
    Malik N; Khatkar A; Dhiman P
    Med Chem; 2020; 16(5):643-653. PubMed ID: 31584375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and biological evaluation of some (1H-1,2,3-triazol-4-yl)methoxybenzaldehyde derivatives containing an anthraquinone moiety as potent xanthine oxidase inhibitors.
    Zhang TJ; Li SY; Yuan WY; Wu QX; Wang L; Yang S; Sun Q; Meng FH
    Bioorg Med Chem Lett; 2017 Feb; 27(4):729-732. PubMed ID: 28131711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.